Synthesis, cardiotonic activity, and structure-activity relationships of 17 beta-guanylhydrazone derivatives of 5 beta-androstane-3 beta, 14 beta-diol acting on the Na+,K(+)-ATPase receptor

J Med Chem. 1997 Oct 10;40(21):3484-8. doi: 10.1021/jm970312l.

Abstract

A series of digitalis-like compounds, with the lactone ring shifted from the original position through a spacer or replaced by a series of guanylhydrazone substituent-bearing chains, was synthesized and evaluated for inhibition of Na+,K(+)-ATPase and for inotropic activity. The highest Na+,K(+)-ATPase inhibition (IC50) and inotropic activity (EC50) were reached with the vinylogous guanylhydrazone 5 where a cardenolide-like polarized alpha,beta-unsaturated system and a basic guanidino group were both present at the 17 beta-position; for this compound IC50 and EC50 values were comparable to or higher than those of Thomas' parent guanylhydrazone 1, digitoxigenin, and digoxin. A substantial improvement of the desired positive inotropic activity versus the toxic arrhythmogenic concentration was not reached within this series; only a slightly better therapeutic index can be envisaged for compounds 5 and 4, even though, for the latter, to the detriment of potency, presumably because of a weaker interaction with the receptor, due to the lack of a cardenolide-like polarized system.

MeSH terms

  • Androstanes / chemical synthesis*
  • Androstanes / chemistry
  • Androstanes / pharmacology*
  • Androstanes / toxicity
  • Animals
  • Arrhythmias, Cardiac / chemically induced
  • Cardiotonic Agents / chemical synthesis*
  • Cardiotonic Agents / chemistry
  • Cardiotonic Agents / pharmacology*
  • Dogs
  • Enzyme Inhibitors / chemical synthesis
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • Guinea Pigs
  • Hydrazones / chemical synthesis*
  • Hydrazones / chemistry
  • Hydrazones / pharmacology*
  • Hydrazones / toxicity
  • Kidney / enzymology
  • Molecular Structure
  • Myocardial Contraction / drug effects
  • Sodium-Potassium-Exchanging ATPase / antagonists & inhibitors*
  • Structure-Activity Relationship

Substances

  • Androstanes
  • Cardiotonic Agents
  • Enzyme Inhibitors
  • Hydrazones
  • Sodium-Potassium-Exchanging ATPase